| __timestamp | Amneal Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 1244910 |
| Thursday, January 1, 2015 | 109679000 | 5029636 |
| Friday, January 1, 2016 | 118757000 | 4846776 |
| Sunday, January 1, 2017 | 109046000 | 5329003 |
| Monday, January 1, 2018 | 230435000 | 7121000 |
| Tuesday, January 1, 2019 | 289598000 | 9128000 |
| Wednesday, January 1, 2020 | 326727000 | 10731000 |
| Friday, January 1, 2021 | 365504000 | 10701000 |
| Saturday, January 1, 2022 | 399700000 | 16121000 |
| Sunday, January 1, 2023 | 429675000 | 37021000 |
Cracking the code
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. From 2014 to 2023, Amneal Pharmaceuticals, Inc. and Viking Therapeutics, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. Amneal's expenses surged by over 400%, peaking in 2023, reflecting strategic investments and expansion. In contrast, Viking's expenses, though significantly lower, increased by nearly 3,000%, indicating a rapid scale-up phase. This stark contrast highlights differing growth strategies: Amneal's steady expansion versus Viking's aggressive scaling. Such insights are invaluable for investors and industry analysts aiming to decode the financial health and strategic direction of these companies. As the pharmaceutical industry evolves, monitoring these trends will be key to understanding market dynamics and future opportunities.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Novartis AG and Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
Selling, General, and Administrative Costs: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Genmab A/S and Amneal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Viking Therapeutics, Inc.
Comparing SG&A Expenses: Catalent, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Blueprint Medicines Corporation or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Vericel Corporation
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared